Biogen (BIIB) ebitda was $3.1B in FY2021 (-36% YoY). The tables below show the complete quarterly and annual ebitda history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual EBITDA
Fiscal Year
EBITDA
YoY
2021
$3.1B
-36%
2020
$4.8B
-34%
2019
$7.3B
+15%
2018
$6.4B
-1%
2017
$6.4B
+12%
2016
$5.7B
-1%
2015
$5.8B
+22%
2014
$4.7B
+48%
2013
$3.2B
+36%
2012
$2.3B
+6%
2011
$2.2B
+20%
2010
$1.8B
-2%
2009
$1.9B
+3%
2008
$1.8B
+42%
2007
$1.3B
Recent Quarterly EBITDA
Quarter
EBITDA
Q1 2026
$959M
Q4 2025
$1.1B
Q3 2025
$971M
Q2 2025
$1.2B
Q1 2025
$1.1B
Q4 2024
$1.4B
Q3 2024
$720M
Q2 2024
$859M
Q1 2024
$942M
Q4 2023
$1.3B
Q3 2023
$346M
Q2 2023
$722M
Source: BIIB on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.